Gene · 6281
Papers4,430
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,430
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-Vesicular Release of Alarmin Prothymosin α Complex Associated with Annexin-2 Flop-Out. | Cells | 2023 | 37371039 | PubTator, text mining | PubMed |
| Whole genome analysis of a novel Spodoptera exigua nucleopolyhedrovirus isolate (SeMNPV-IR) to Iran. | Biologia (Bratisl) | 2023 | 37363644 | PubTator, text mining | PubMed |
| A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases. | Clin Transl Immunology | 2023 | 37360982 | PubTator, text mining | PubMed |
| Spinal cord injury: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37357239 | PubTator, text mining | PubMed |
| The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer. | Cancers (Basel) | 2023 | 37345089 | PubTator, text mining | PubMed |
| "You're stuck in the middle here": a qualitative study of GPs' experiences of managing knee pain attributed to a degenerative meniscal tear. | BMC Prim Care | 2023 | 37344762 | PubTator, text mining | PubMed |
| Molecular choreography of primer synthesis by the eukaryotic Pol α-primase. | Nat Commun | 2023 | 37344454 | PubTator, text mining | PubMed |
| The inhibitory effect of quercetin-3-glucuronide on pulmonary injury in vitro and in vivo. | J Food Drug Anal | 2023 | 37335159 | PubTator, text mining | PubMed |
| Cathepsins in oral diseases: mechanisms and therapeutic implications. | Front Immunol | 2023 | 37334378 | PubTator, text mining | PubMed |
| Peptide MSI-1 inhibited MCR-1 and regulated outer membrane vesicles to combat immune evasion of Escherichia coli. | Microb Biotechnol | 2023 | 37329166 | PubTator, text mining | PubMed |
| Explaining the perspective of people living with HIV on health-promoting behaviours based on Pender's model: A directed content analysis. | Nurs Open | 2023 | 37327121 | PubTator, text mining | PubMed |
Adjuvant therapy with Huatan Sanjie Granules improves the prognosis of patients with primary liver cancer: a cohort study and the investigation of its mechanism of action based on network pharmacology. | Front Pharmacol | 2023 | 37324453 | PubTator, text mining | PubMed |
| Clonal hematopoiesis is associated with protection from Alzheimer's disease. | Nat Med | 2023 | 37322115 | PubTator, text mining | PubMed |
| [S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway]. | Nan Fang Yi Ke Da Xue Xue Bao | 2023 | 37313814 | PubTator, text mining | PubMed |
| Activity, substrate preference and structure of the HsMCM8/9 helicase. | Nucleic Acids Res | 2023 | 37309874 | PubTator, text mining | PubMed |
| Integrative multi-omics approach for identifying molecular signatures and pathways and deriving and validating molecular scores for COVID-19 severity and status. | BMC Genomics | 2023 | 37308820 | PubTator, text mining | PubMed |
| Nelson Bay Reovirus Isolated from Bats and Blood-Sucking Arthropods Collected in Yunnan Province, China. | Microbiol Spectr | 2023 | 37306586 | PubTator, text mining | PubMed |
| Nonstructural protein NS17 of grass carp reovirus Honghu strain promotes virus infection by mediating cell-cell fusion and apoptosis. | Virus Res | 2023 | 37302658 | PubTator, text mining | PubMed |
| Molecular characterization, complete genome sequencing, and pathogenicity of Novel Duck Reovirus from South Coastal Area in China. | Poult Sci | 2023 | 37302330 | PubTator, text mining | PubMed |
| Long-Chain Acyl Coenzyme A Dehydrogenase, a Key Player in Metabolic Rewiring/Invasiveness in Experimental Tumors and Human Mesothelioma Cell Lines. | Cancers (Basel) | 2023 | 37297007 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6281/papers?page=22